NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
Felix Knauf, John R Asplin, Ignacio Granja, Insa M Schmidt, Gilbert W Moeckel, Rachel J David, Richard A Flavell, Peter S Aronson, Felix Knauf, John R Asplin, Ignacio Granja, Insa M Schmidt, Gilbert W Moeckel, Rachel J David, Richard A Flavell, Peter S Aronson
Abstract
Oxalate nephropathy with renal failure is caused by multiple disorders leading to hyperoxaluria due to either overproduction of oxalate (primary hyperoxaluria) or excessive absorption of dietary oxalate (enteric hyperoxaluria). To study the etiology of renal failure in crystal-induced kidney disease, we created a model of progressive oxalate nephropathy by feeding mice a diet high in soluble oxalate (high oxalate in the absence of dietary calcium). Renal histology was characterized by intratubular calcium-oxalate crystal deposition with an inflammatory response in the surrounding interstitium. Oxalate nephropathy was not found in mice fed a high oxalate diet that also contained calcium. NALP3, also known as cryopyrin, has been implicated in crystal-associated diseases such as gout and silicosis. Mice fed the diet high in soluble oxalate demonstrated increased NALP3 expression in the kidney. Nalp3-null mice were completely protected from the progressive renal failure and death that occurred in wild-type mice fed the diet high in soluble oxalate. NALP3 deficiency did not affect oxalate homeostasis, thereby excluding differences in intestinal oxalate handling to explain the observed phenotype. Thus, progressive renal failure in oxalate nephropathy results primarily from NALP3-mediated inflammation.
Figures
References
- Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol. 2003;18:986–991.
- Cartery C, Faguer S, Karras A, et al. Oxalate nephropathy associated with chronic pancreatitis. Clin J Am Soc Nephrol. 2011;6:1895–1902.
- Lefaucheur C, Nochy D, Amrein C, et al. Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Tranplantation. 2008;8:1901–1910.
- Capolongo G, Abul-Ezz S, Moe OW, et al. Subclinical celiac disease and crystal-induced kidney disease following kidney transplant. Am J Kidney Dis. 2012;60:662–667.
- Mandell I, Krauss E, Millan JC. Oxalate-induced acute renal failure in Crohn’s disease. Am J Med. 1980;69:628–632.
- Hueppelshaeuser R, von Unruh GE, Habbig S, et al. Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn’s disease. Pediatr Nephrol. 2012;27:1103–1109.
- Chen CL, Fang HC, Chou KJ, et al. Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis. 2001;37:418–422.
- Nasr SH, D’Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3:1676–1683.
- Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459–465.
- Hoppe B. An update on primary hyperoxaluria. Nature reviews Nephrology. 2012;8:467–475.
- Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002;31:979–999.
- Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. The New England Journal of Medicine. 2010;363:954–963.
- Gross O, Thomas CJ, Guarda G, et al. The inflammasome: an integrated view. Immunological Reviews. 2011;243:136–151.
- Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–241.
- Cassel SL, Eisenbarth SC, Iyer SS, et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105:9035–9040.
- Dostert C, Ptrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674–677.
- Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22:1007–1018.
- Vilaysane A, Chun J, Seamone ME, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. Journal of the American Society of Nephrology: JASN. 2010;21:1732–1744.
- Shigeoka AA, Mueller JL, Kambo A, et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 2010;185:6277–6285.
- Iyer SS, Pulskens WP, Sadler JJ, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A. 2009;106:20388–20393.
- Knauf F, Ko N, Jiang Z, et al. Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion. J Am Soc Nephrol. 2011;22:2247–2255.
- Hess B, Jost C, Zipperle L, et al. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant. 1998;13:2241–2247.
- Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270–276.
- Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol. 2004;8:75–88.
- Jin C, Frayssinet P, Pelker R, et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci U S A. 2011;108:14867–14872.
- Mulay SR, Kulkarni OP, Rupanagudi KV, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J Clin Invest. 2013;123:236–246.
- Watson CJ, Hoare CJ, Garrod DR, et al. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. Journal of Cell Science. 2005;118:5221–5230.
- Hoppe B, Kemper MJ, Hvizd MG, et al. Simultaneous determination of oxalate, citrate and sulfate in children’s plasma with ion chromatography. Kidney Int. 1998;53:1348–1352.
- Takahashi N, Boysen G, Li F, et al. Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int. 2007;71:266–271.
- Hopfer H, Holzer J, Hunemorder S, et al. Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis. Kidney Int. 2012;82:60–71.
- Ko N, Knauf F, Jiang Z, et al. Sat1 is dispensable for active oxalate secretion in mouse duodenum. Am J Physiol Cell Physiol. 2012;303:C52–57.
Source: PubMed